RSS Atom • ISSN 1472-4683 • Subscribe • About
Resistance
- Phenotypic resistance to ddI is less frequent than resistance to ZDV, 3TC and abacavir Conference reports - Resistance - ICAAC 41st Chicago 2001 - 9 January 2002
- HIV drug resistance can develop under HAART at low levels of viraemia Conference reports - Resistance - EACS 8 Athens 2001 - 2 November 2001
- GigaHAART study shows benefit of treatment interruption prior to treatment with >7 drugs in highly treatment experienced patients Conference reports - Resistance - EACS 8 Athens 2001 - 2 November 2001
- Resistance to nevirapine differs by HIV-1 subtype PMTCT and maternal health - Resistance - 1 October 2001
- Anti-HIV immune responses and partial viral suppression Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- HIV resistance, phenotypic drug susceptibility and viral fitness Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- SWATCH – alternating antiretroviral regimens Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- Structured treatments interruptions Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- Importance of additional active drugs for NNRTI-naive patients using NNRTI-based salvage regimens Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- NNRTI and PI drug plasma levels are as critical as drug sensitivity in achieving treatment success in antiretroviral experienced patients Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- Increased prevalence of transmission of drug resistant HIV and reduced response in newly infected subjects in nine US cities Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- Role of codon-69 variants in reduced susceptibility to nucleoside analogues Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- Selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug naive people Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- Nucleoside resistance pathways may differ between HIV-1 and HIV-2 Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- Role of Y318F mutation in NNRTI resistance Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 30 July 2001
- Prevalence of the T215Y mutation in HIV type 1-infected pregnant women in a New York cohort, 1995-1999 PMTCT and maternal health - Resistance - 30 July 2001
- Impaired replication of protease inhibitor-resistant HIV-1 in human thymus Basic science and immunology - Resistance - 30 July 2001
- Paediatric treatment issues at the 8th CROI Conference reports - Paediatric care - Resistance - CROI 8 (Retrovirus) 2001 - 17 April 2001
- Update on HIV drug resistance Conference reports - Resistance - CROI 8 (Retrovirus) 2001 - 17 March 2001
- MDR resistance transmission increases in the UK Conference reports - Resistance - HIV 5 Glasgow 2000 - 17 December 2000
- Treatment interruption and salvage therapy Conference reports - Resistance - ICAAC 40th Toronto 2000 - 17 October 2000
- Tenofovir (PMPA), defining cross-resistance profiles Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Mycophenalate mofetil in patients with advanced disease and multidrug resistant HIV Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Hydroxyurea is active in vitro against multidrug-resistant HIV Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- ABT-378/r (Lopinavir): defining a resistance profile and the effects of resistance on virological response in experienced patients Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Phenotypic resistance testing improves response to therapy: final analysis of VIRA3001 Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Continued benefits from protease inhibitor based therapy despite virological failure Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Do resistance mutations disappear off therapy? Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Selection of PI mutations during slow decay of VL and resistance after PI failure Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Thymidine analogues mutations (TAMS) and other NA-related resistance mutations Conference reports - Resistance - Intl Drug Resistance Workshop 4 Sitges 2000 - 16 July 2000
- Immune response may persist after emergence of protease inhibitor-resistant HIV Resistance - 16 July 2000
- Clinical studies of indinavir/ritonavir as salvage therapy Conference reports - Resistance - Int Workshop on Salvage Therapy 3rd - 15 May 2000
- Indinavir plus ritonavir: might exposure to higher levels of indinavir overcome protease resistant HIV and prove useful to 'rescue' previously failed protease inhibitor based combinations? Conference reports - Resistance - Int Workshop on Salvage Therapy 3rd - 15 May 2000